Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Some plant extracts may treat livestock diseases, certain animal treatments are safe and effective, but more research on drug safety and resistance is needed.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Biomaterials with MSC-derived substances could improve tissue repair and have advantages over direct cell therapy.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Stem cells help heal skin wounds by moving and changing roles, working with other cells, and needing more research on their activation and behavior.

Some medicinal plants can help heal wounds and may lead to new treatments.

Blocking COX, especially COX-2, in the skin can reduce inflammation and pain and may help prevent skin cancer.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

Fetal wound healing changes with development, affecting inflammation and collagen, which may influence scarring.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Engineered exosomes show promise for improving wound healing but face challenges in clinical use.

FFA's causes may include environmental triggers and genetic factors.

Toll-like receptors are important for wound healing, but can slow it down in diabetic wounds.

Testosterone may slow down wound healing and increase inflammation.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Hair can regrow after certain stem cells are lost because other stem cells can take over their role.

Loss of OGG1 increases skin inflammation and auto-antibodies in lupus.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Genetics play a role in acne, but how exactly they contribute is not fully understood.

Mice lacking fibromodulin have disrupted healing patterns, leading to abnormal skin repair and scarring.